Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Open Access Highly Accessed Research

Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program

Doug Elliott1*, Sharon McKinley2, Jennifer Alison3, Leanne M Aitken4, Madeleine King5, Gavin D Leslie6, Patricia Kenny7, Penny Taylor1, Rachel Foley8 and Elizabeth Burmeister9

Author Affiliations

1 Faculty of Nursing, Midwifery and Health, University of Technology, Sydney, 15 Broadway, Ultimo, 2007, Australia

2 University of Technology, Sydney and Northern Sydney Local Health Network, Sydney,15 Broadway, Ultimo, 2007, Australia

3 Faculty of Health Sciences, The University of Sydney, 75 East Street, Lidcombe, 2141, Australia

4 Princess Alexandra Hospital and Griffith University, 199 Ipswich Road, Woolloongabba, 4102, Australia

5 School of Psychology, University of Sydney, Fisher Road, Sydney, 2006, Australia

6 School of Nursing and Midwifery, Curtin Health Innovation Research Institute, Curtin University and Royal Perth Hospital, Kent Street, Bentley, 6102, Australia

7 Centre for Health Economics Research and Evaluation, University of Technology, Sydney, 15 Broadway, Ultimo, 2007, Australia

8 Critical Care Nursing Professorial Unit, University of Technology, Sydney and Northern Sydney Local Health Network, 15 Broadway, Ultimo, 2007, Australia

9 Nursing Practice and Development Unit, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, 4102, Australia

For all author emails, please log on.

Critical Care 2011, 15:R142  doi:10.1186/cc10265


See related commentary by Herridge, http://ccforum.com/content/15/5/1002

Published: 9 June 2011

Abstract

Introduction

Significant physical sequelae exist for some survivors of a critical illness. There are, however, few studies that have examined specific interventions to improve their recovery, and none have tested a home-based physical rehabilitation program incorporating trainer visits to participants' homes. This study was designed to test the effect of an individualised eight-week home-based physical rehabilitation program on recovery.

Methods

A multi-centre randomised controlled trial design was used. Adult intensive care patients (length of stay of at least 48 hours and mechanically ventilated for 24 hours or more) were recruited from 12 Australian hospitals between 2005 and 2008. Graded, individualised endurance and strength training intervention was prescribed over eight weeks, with three physical trainer home visits, four follow-up phone calls, and supported by a printed exercise manual. The main outcome measures were blinded assessments of physical function; SF-36 physical function (PF) scale and six-minute walk test (6MWT), and health-related quality of life (SF-36) conducted at 1, 8 and 26 weeks after hospital discharge.

Results

Of the 195 participants randomised, 183, 173 and 161 completed the 1, 8 and 26 weeks assessments, respectively. Study groups were similar at Week 1 post-hospital; for the intervention and control groups respectively, mean norm-based PF scores were 27 and 29 and the 6MWT distance was 291 and 324 metres. Both groups experienced significant and clinically important improvements in PF scores and 6MWT distance at 8 weeks, which persisted at 26 weeks. Mixed model analysis showed no significant group effects (P = 0.84) or group by time interactions (P = 0.68) for PF. Similar results were found for 6MWT and the SF-36 summary scores.

Conclusions

This individualised eight-week home-based physical rehabilitation program did not increase the underlying rate of recovery in this sample, with both groups of critically ill survivors improving their physical function over the 26 weeks of follow-up. Further research should explore improving effectiveness of the intervention by increasing exercise intensity and frequency, and identifying individuals who would benefit most from this intervention.

Trial registration

Australia and New Zealand Clinical Trials Register ACTRN12605000166673